➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
McKesson
Mallinckrodt
Express Scripts
Merck

Last Updated: May 24, 2020

DrugPatentWatch Database Preview

Litigation Details for CELGENE CORPORATION v. EMCURE PHARMACEUTICALS LTD. (D.N.J. 2018)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

CELGENE CORPORATION v. EMCURE PHARMACEUTICALS LTD. (D.N.J. 2018)

Docket   Start Trial Date Filed 2018-06-28
Court District Court, D. New Jersey Date Terminated
Cause 15:1126 Patent Infringement Assigned To Michael Andre Shipp
Jury Demand None Referred To Douglas E. Arpert
Parties CELGENE CORPORATION; EMCURE PHARMACEUTICALS LTD.; HERITAGE PHARMACEUTICALS INC.
Patents 10,092,541; 6,020,358; 6,962,940; 7,427,638; 7,893,101; 9,872,854
Attorneys CHARLES MICHAEL LIZZA; DAVID C. KISTLER; DAVID LEIGH MOSES; JAY P. LESSLER; MICHAEL RAY DARBEE; SARAH A GEERS; SARAH ANN SULLIVAN; WILLIAM C. BATON
Firms Blank Rome LLP, the Chrysler Building; Jones Day; Saul Ewing Arnstein & Lehr LLP
Link to Docket External link to docket
Small Molecule Drugs cited in CELGENE CORPORATION v. EMCURE PHARMACEUTICALS LTD.
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in CELGENE CORPORATION v. EMCURE PHARMACEUTICALS LTD.

Details for CELGENE CORPORATION v. EMCURE PHARMACEUTICALS LTD. (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 23 Amended Complaint (“the ’854 Patent”), and 10,092,541 (“the ’541 Patent”) (collectively, “the Patents-in-Suit”). … United States Patent Nos. 7,427,638 (“the ’638 Patent”), 7,893,101 (“the ’101 Patent”), 9,872,854 (…infringement of the ’541 Patent in addition to the ’638 Patent and the ’854 Patent, on November 8, 2018… This is a civil action for patent infringement arising under the patent laws of the United States,… This is a civil action for patent infringement arising under the patent laws of the United States, External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Harvard Business School
Express Scripts
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.